-
Product Insights
Ginkgo Mine
The Ginkgo Mine is a ilmenite mine in Australia. It is currently in operation. Empower your strategies with our Ginkgo Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain vital information...
-
Company Insights
Innovation and Patenting activity of Ginkgo Bioworks Holdings Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Ginkgo Bioworks Holdings Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
Cardiomyopathy – Drugs In Development, 2023
Global Markets Direct’s, ‘Cardiomyopathy - Drugs In Development, 2023’, provides an overview of the Cardiomyopathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cardiomyopathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Neuroblastoma – Drugs In Development, 2023
Global Markets Direct’s, ‘Neuroblastoma - Drugs In Development, 2023’, provides an overview of the Neuroblastoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Neuroblastoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Track & Monitor
Artificial intelligence in pharma: drug repurposing AI
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the pharma industry’s drug repurposing AI segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Product Insights
Plasma Cell Neoplasm – Drugs In Development, 2023
Global Markets Direct’s, ‘Plasma Cell Neoplasm - Drugs In Development, 2023’, provides an overview of the Plasma Cell Neoplasm pipeline landscape. The report provides comprehensive information on the therapeutics under development for Plasma Cell Neoplasm, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Thematic Analysis
Synthetic Biology – Thematic Intelligence
Synthetic Biology Thematic Report Overview Synthetic biology is commonly abbreviated to synbio. It involves the manipulation of genetic material to enhance specific characteristics or, conversely, stifle them. The ability to perform this manipulation quickly, precisely, and at a low cost has the potential to impact numerous sectors. From developing environmentally friendly luxury materials to novel cancer therapeutics and even the use of DNA as a new form of data storage, the forthcoming field of synbio unlocks several new realms of...
-
Sector Analysis
Green Bites – Key Disruptive Forces in Sustainable Nutrition
Disruptive Forces in Sustainable Nutrition Report Overview Advanced developments such as edible insects, food 3D printing, and plant-based proteins are redefining food efficiency and environmental impact in the sustainable nutrition domain. Innovation Curve: Consumer Buy the Full Report to Know More about the Disruptive Forces in Sustainable Nutrition Download a Free Report Sample The ‘Green Bites – Key Disruptive Forces in Sustainable Nutrition’ FutureTech series report categorizes the key innovation areas in sustainable nutrition as emerging, accelerating, and maturing. The...
-
Company Profile
Ginkgo Bioworks Holdings Inc – Company Profile
Ginkgo Bioworks Holdings Inc (Ginkgo Bioworks) is a biotechnology company that builds a leading platform for cell programming and biosecurity and provides automated organism engineering, enzyme discovery, fermentation and cultured fragrance solutions through its subsidiary. The company is into genetic engineering to produce bacteria with industrial applications. Its cell programming platform is used to program cells to enable the biological production of products, such as food ingredients, novel therapeutics, and chemicals. Ginkgo Bioworks offerings include vaccines, enzymes, proteins, small molecules,...
Add to Basket